BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26806308)

  • 1. miR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancer.
    Zhou WB; Zhong CN; Luo XP; Zhang YY; Zhang GY; Zhou DX; Liu LP
    Biochem Biophys Res Commun; 2016 Feb; 470(4):838-44. PubMed ID: 26806308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGA1 Overexpression is Associated With the Malignant Status and Progression of Breast Cancer.
    Qi C; Cao J; Li M; Liang C; He Y; Li Y; Li J; Zheng X; Wang L; Wei B
    Anat Rec (Hoboken); 2018 Jun; 301(6):1061-1067. PubMed ID: 29316384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer.
    Hu JY; Yi W; Wei X; Zhang MY; Xu R; Zeng LS; Huang ZJ; Chen JS
    Biomed Pharmacother; 2016 Apr; 79():247-53. PubMed ID: 27044835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
    Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
    Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant Expression of miR-142-3p and its Target Gene HMGA1 and FZD7 in Breast Cancer and its Clinical Significance.
    Jia XP; Meng LL; Fang JC; Wang HW; Chen J; Zhou J; Wang CN; Jiang WF
    Clin Lab; 2018 Jun; 64(6):915-921. PubMed ID: 29945308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of miR-26a and HMGA1 in urothelial bladder cancer.
    Lin R; Shen W; Zhi Y; Zhou Z
    Biomed Pharmacother; 2014 Oct; 68(8):929-34. PubMed ID: 25455159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
    Fu F; Wang T; Wu Z; Feng Y; Wang W; Zhou S; Ma X; Wang S
    Cell Death Dis; 2018 May; 9(6):594. PubMed ID: 29789601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting HMGA1.
    Xu G; Wang J; Jia Y; Shen F; Han W; Kang Y
    Cell Physiol Biochem; 2014; 33(5):1329-39. PubMed ID: 24803022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
    Cui W; Zhang S; Shan C; Zhou L; Zhou Z
    FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1.
    Liu K; Zhang C; Li T; Ding Y; Tu T; Zhou F; Qi W; Chen H; Sun X
    Int J Oncol; 2015; 46(6):2526-34. PubMed ID: 25846193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met.
    Wu ZS; Wu Q; Wang CQ; Wang XN; Huang J; Zhao JJ; Mao SS; Zhang GH; Xu XC; Zhang N
    Cancer; 2011 Jul; 117(13):2842-52. PubMed ID: 21692045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGA1 protein expression in familial breast carcinoma patients.
    Chiappetta G; Ottaiano A; Vuttariello E; Monaco M; Galdiero F; Gallipoli A; Pilotti S; Jodice G; Siranoush M; Colombo M; Ripamonti CB; Pallante PL; Radice P; Fusco A
    Eur J Cancer; 2010 Jan; 46(2):332-9. PubMed ID: 19896837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asiaticoside Suppresses Gastric Cancer Progression and Induces Endoplasmic Reticulum Stress through the miR-635/HMGA1 Axis.
    Zhang C; Ji X; Chen Z; Yao Z
    J Immunol Res; 2022; 2022():1917585. PubMed ID: 35692504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation.
    Kaddar T; Rouault JP; Chien WW; Chebel A; Gadoux M; Salles G; Ffrench M; Magaud JP
    Biol Cell; 2009 Sep; 101(9):511-24. PubMed ID: 19250063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGA1-Regulating microRNAs Let-7a and miR-26a are Downregulated in Human Seminomas.
    De Martino M; Esposito F; Pellecchia S; Cortez Cardoso Penha R; Botti G; Fusco A; Chieffi P
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
    Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer.
    Chen B; Tang H; Liu X; Liu P; Yang L; Xie X; Ye F; Song C; Xie X; Wei W
    Cancer Lett; 2015 Jan; 356(2 Pt B):410-7. PubMed ID: 25304371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells.
    Panneerselvam J; Srivastava A; Muralidharan R; Wang Q; Zheng W; Zhao L; Chen A; Zhao YD; Munshi A; Ramesh R
    Oncotarget; 2016 Oct; 7(43):70247-70263. PubMed ID: 27602961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.